A high blood endocan profile during COVID-19 distinguishes moderate from severe acute respiratory distress syndrome
Tiffany Pascreau(Inserm), Philippe Lassalle(Centre National de la Recherche Scientifique), Marc Vasse(Hôpital Foch), Colas Tchérakian(Inserm), Benjamin Zuber(Hôpital Foch), Éric Farfour(European Foundation for Clinical Nanomedicine)
Cited by 15
Related Papers
International clinical guidelines for the management of phosphomannomutase 2‐congenital disorders of glycosylation: Diagnosis, treatment and follow up
|Journal of Inherited Metabolic Disease|2019|149
Endocan, sepsis, pneumonia, and acute respiratory distress syndrome
|Critical Care|2018|142